PFRM3 Statistics

Total Valuation

Profarma Distribuidora de Produtos Farmacêuticos has a market cap or net worth of BRL 752.83 million. The enterprise value is 2.22 billion.

Market Cap	752.83M
Enterprise Value	2.22B

Important Dates

The next estimated earnings date is Wednesday, November 6, 2024.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

Profarma Distribuidora de Produtos Farmacêuticos has 122.61 million shares outstanding.

Shares Outstanding	122.61M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.45%
Owned by Institutions (%)	18.89%
Float	40.68M

Valuation Ratios

The trailing PE ratio is 8.31.

PE Ratio	8.31
Forward PE	n/a
PS Ratio	0.08
PB Ratio	0.58
P/FCF Ratio	1.54
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.27, with an EV/FCF ratio of 4.55.

EV / Earnings	24.46
EV / Sales	0.25
EV / EBITDA	5.27
EV / EBIT	7.73
EV / FCF	4.55

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 85.23.

Current Ratio	1.44
Quick Ratio	0.77
Debt / Equity	85.23
Debt / EBITDA	3.18
Debt / FCF	2.74
Interest Coverage	1.82

Financial Efficiency

Return on equity (ROE) is 6.45% and return on invested capital (ROIC) is 6.16%.

Return on Equity (ROE)	6.45%
Return on Assets (ROA)	3.75%
Return on Capital (ROIC)	6.16%
Revenue Per Employee	1.28M
Profits Per Employee	12,800
Employee Count	7,077
Asset Turnover	1.89
Inventory Turnover	5.26

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +63.13% in the last 52 weeks. The beta is 1.33, so Profarma Distribuidora de Produtos Farmacêuticos's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	+63.13%
50-Day Moving Average	5.90
200-Day Moving Average	5.48
Relative Strength Index (RSI)	50.50
Average Volume (20 Days)	211,330

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Profarma Distribuidora de Produtos Farmacêuticos had revenue of BRL 9.04 billion and earned 90.58 million in profits. Earnings per share was 0.74.

Revenue	9.04B
Gross Profit	1.38B
Operating Income	286.48M
Pretax Income	112.79M
Net Income	90.58M
EBITDA	316.77M
EBIT	286.48M
Earnings Per Share (EPS)	0.74

Full Income Statement

Balance Sheet

The company has 155.08 million in cash and 1.34 billion in debt, giving a net cash position of -1.18 billion or -9.64 per share.

Cash & Cash Equivalents	155.08M
Total Debt	1.34B
Net Cash	-1.18B
Net Cash Per Share	-9.64
Equity (Book Value)	1.57B
Book Value Per Share	10.51
Working Capital	1.07B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 571.14 million and capital expenditures -83.70 million, giving a free cash flow of 487.44 million.

Operating Cash Flow	571.14M
Capital Expenditures	-83.70M
Free Cash Flow	487.44M
FCF Per Share	3.98

Full Cash Flow Statement

Margins

Gross margin is 15.28%, with operating and profit margins of 3.17% and 1.00%.

Gross Margin	15.28%
Operating Margin	3.17%
Pretax Margin	1.25%
Profit Margin	1.00%
EBITDA Margin	3.50%
EBIT Margin	3.17%
FCF Margin	5.39%

Dividends & Yields

This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 1.87%.

Dividend Per Share	0.12
Dividend Yield	1.87%
Dividend Growth (YoY)	122.58%
Years of Dividend Growth	n/a
Payout Ratio	45.94%
Buyback Yield	n/a
Shareholder Yield	1.87%
Earnings Yield	12.03%
FCF Yield	64.75%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a